Unicon Fibro Chemicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 16-06-2024
- Paid Up Capital ₹ 1.00 Cr
as on 16-06-2024
- Company Age 37 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 19.04 Cr
as on 16-06-2024
- Satisfied Charges ₹ 7.60 Cr
as on 16-06-2024
- Revenue -46.83%
(FY 2023)
- Profit -64.50%
(FY 2023)
- Ebitda -13.06%
(FY 2023)
- Net Worth 5.33%
(FY 2023)
- Total Assets 1.16%
(FY 2023)
About Unicon Fibro Chemicals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹19.04 Cr. The company has closed loans amounting to ₹7.60 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rajeshwari Pradhan, Siddhart Pradhan, and Ashwin Pradhan serve as directors at the Company.
- CIN/LLPIN
U24100MH1987PTC042066
- Company No.
042066
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jan 1987
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Unicon Fibro Chemicals Pvt Ltd offer?
Unicon Fibro Chemicals Pvt Ltd offers a wide range of products and services, including Chemical Reagents & Catalysts, Fatty Esters.
Who are the key members and board of directors at Unicon Fibro Chemicals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajeshwari Pradhan  | Director | 01-Jan-1987 | Current |
| Siddhart Pradhan | Director | 05-Apr-2021 | Current |
| Ashwin Pradhan | Director | 05-Jul-2021 | Current |
Financial Performance and Corporate Structure Insights of Unicon Fibro Chemicals.
Unicon Fibro Chemicals Pvt Ltd, for the financial year ended 2023, experienced significant reduction in revenue, with a 46.83% decrease. The company also saw a substantial fall in profitability, with a 64.5% decrease in profit. The company's net worth moved up by a moderate rise of 5.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Unicon Fibro Chemicals?
In 2023, Unicon Fibro Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 06 Nov 2006 | ₹19.00 Cr | Open |
Bank Of Maharashtra Creation Date: 19 Apr 1989 | ₹0.35 M | Open |
Nkgsb Co.Op. Bank Ltd. Creation Date: 21 Jul 2014 | ₹1.65 Cr | Satisfied |
How Many Employees Work at Unicon Fibro Chemicals?
Unicon Fibro Chemicals has a workforce of 21 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unicon Fibro Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unicon Fibro Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
